Invesco’s BioAge Labs BIOA Stock Holding History

Invesco’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.12M	Sell	127,420 -48,690	-28%	-$880K	﹤0.01%	2404
2026 Q1	$3.08M	Sell	176,110 -52,563	-23%	-$1.01M	﹤0.01%	2369
2025 Q4	$3.03M	Buy	+228,673	New	+$2.03M	﹤0.01%	2449

Other funds holding BIOA

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Jupiter Topco New York $245B AUM

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Invesco's BIOA Position: Q2 2026 in Review

Invesco reduced its BioAge Labs (BIOA) stake by 28% in Q2 2026, selling an estimated $880K and leaving 127,420 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2404.

Invesco first reported a position in BIOA in Q4 2025 and has held it in 3 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

Invesco held 127,420 shares of BioAge Labs worth $3.12M as of Q2 2026.
Invesco sold 48,690 BioAge Labs shares in Q2 2026, an estimated $880K.
BioAge Labs made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2404 holding.
Invesco first reported a position in BioAge Labs in Q4 2025 and has held it in 3 quarters since.
151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.